147 related articles for article (PubMed ID: 17047386)
1. Cancers associated with acromegaly.
Jenkins PJ
Neuroendocrinology; 2006; 83(3-4):218-23. PubMed ID: 17047386
[TBL] [Abstract][Full Text] [Related]
2. Acromegaly and cancer.
Jenkins PJ
Horm Res; 2004; 62 Suppl 1():108-15. PubMed ID: 15761242
[TBL] [Abstract][Full Text] [Related]
3. Clinical perspective: acromegaly and cancer: a problem.
Jenkins PJ; Besser M
J Clin Endocrinol Metab; 2001 Jul; 86(7):2935-41. PubMed ID: 11443146
[No Abstract] [Full Text] [Related]
4. Detection of colorectal lesions by using autofluorescence colonoscopy in acromegalics and their relation to serum growth hormone and insulin-like growth factor-1 levels.
Matyja V; Kos-Kudla B; Foltyn W; Strzelczyk J; Latos W; Marek B; Kajdaniuk D; Karpe J; Ostrowska Z; Sieron-Stoltny K; Sieron A
Neuro Endocrinol Lett; 2006 Oct; 27(5):639-43. PubMed ID: 17159821
[TBL] [Abstract][Full Text] [Related]
5. Acromegaly and colorectal cancer: a comprehensive review of epidemiology, biological mechanisms, and clinical implications.
Renehan AG; O'Connell J; O'Halloran D; Shanahan F; Potten CS; O'Dwyer ST; Shalet SM
Horm Metab Res; 2003; 35(11-12):712-25. PubMed ID: 14710350
[TBL] [Abstract][Full Text] [Related]
6. Risk of colorectal neoplasm in patients with acromegaly and its relationship with serum growth hormone levels.
Matano Y; Okada T; Suzuki A; Yoneda T; Takeda Y; Mabuchi H
Am J Gastroenterol; 2005 May; 100(5):1154-60. PubMed ID: 15842593
[TBL] [Abstract][Full Text] [Related]
7. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.
Jayasena CN; Comninos AN; Clarke H; Donaldson M; Meeran K; Dhillo WS
Clin Endocrinol (Oxf); 2011 Aug; 75(2):220-5. PubMed ID: 21521288
[TBL] [Abstract][Full Text] [Related]
8. The PPAR-gamma activator rosiglitazone fails to lower plasma growth hormone and insulin-like growth factor-1 levels in patients with acromegaly.
Bastemir M; Akin F; Yaylali GF
Neuroendocrinology; 2007; 86(2):119-23. PubMed ID: 17671378
[TBL] [Abstract][Full Text] [Related]
9. Is there any relation between hyperinsulinemia, insulin resistance and colorectal lesions in patients with acromegaly?
Foltyn W; Kos-Kudla B; Strzelczyk J; Matyja V; Karpe J; Rudnik A; Marek B; Kajdaniuk D; Sieron A; Latos W
Neuro Endocrinol Lett; 2008 Feb; 29(1):107-12. PubMed ID: 18283256
[TBL] [Abstract][Full Text] [Related]
10. Acromegaly: re-thinking the cancer risk.
Loeper S; Ezzat S
Rev Endocr Metab Disord; 2008 Mar; 9(1):41-58. PubMed ID: 18157698
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor I and the development of colorectal neoplasia in acromegaly.
Jenkins PJ; Frajese V; Jones AM; Camacho-Hubner C; Lowe DG; Fairclough PD; Chew SL; Grossman AB; Monson JP; Besser GM
J Clin Endocrinol Metab; 2000 Sep; 85(9):3218-21. PubMed ID: 10999811
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women.
Giovannucci E; Pollak MN; Platz EA; Willett WC; Stampfer MJ; Majeed N; Colditz GA; Speizer FE; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):345-9. PubMed ID: 10794477
[TBL] [Abstract][Full Text] [Related]
13. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
14. Acromegaly, growth hormone and cancer risk.
Renehan AG; Brennan BM
Best Pract Res Clin Endocrinol Metab; 2008 Aug; 22(4):639-57. PubMed ID: 18971124
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance, apoptosis, and colorectal adenoma risk.
Keku TO; Lund PK; Galanko J; Simmons JG; Woosley JT; Sandler RS
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2076-81. PubMed ID: 16172212
[TBL] [Abstract][Full Text] [Related]
16. [Serum concentration of insulin, C-peptide and insulin-like growth factor I in patients with colon adenomas and colorectal cancer].
Kaczka A; Kumor A; Pietruczuk M; Małecka-Panas E
Pol Merkur Lekarski; 2007 May; 22(131):373-5. PubMed ID: 17679371
[TBL] [Abstract][Full Text] [Related]
17. Cancer risk factors associated with insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels in healthy women: effect modification by menopausal status.
Barnes BB; Chang-Claude J; Flesch-Janys D; Kinscherf R; Schmidt M; Slanger T; Bonaterra G; Steindorf K
Cancer Causes Control; 2009 Dec; 20(10):1985-96. PubMed ID: 19597750
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of differentiated thyroid carcinoma in acromegaly.
Tita P; Ambrosio MR; Scollo C; Carta A; Gangemi P; Bondanelli M; Vigneri R; degli Uberti EC; Pezzino V
Clin Endocrinol (Oxf); 2005 Aug; 63(2):161-7. PubMed ID: 16060909
[TBL] [Abstract][Full Text] [Related]
19. Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution.
Jallad RS; Musolino NR; Salgado LR; Bronstein MD
Clin Endocrinol (Oxf); 2005 Aug; 63(2):168-75. PubMed ID: 16060910
[TBL] [Abstract][Full Text] [Related]
20. Does growth hormone cause cancer?
Jenkins PJ; Mukherjee A; Shalet SM
Clin Endocrinol (Oxf); 2006 Feb; 64(2):115-21. PubMed ID: 16430706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
